Eddy Anglade
Amministratore Delegato presso Tenpoint Therapeutics Ltd.
Posizioni attive di Eddy Anglade
Società | Posizione | Inizio | Fine |
---|---|---|---|
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Direttore/Membro del Consiglio | 12/07/2023 | - |
Amministratore Delegato | 12/07/2023 | - |
Storia della carriera di Eddy Anglade
Precedenti posizioni note di Eddy Anglade
Società | Posizione | Inizio | Fine |
---|---|---|---|
OCATA THERAPEUTICS INC | Direttore Tecnico/Scientifico/R&S | 01/01/2014 | 10/02/2016 |
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 | 01/07/2013 |
Fondatore | 21/10/2009 | 01/07/2013 | |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Direttore Tecnico/Scientifico/R&S | - | - |
ENZON PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Formazione di Eddy Anglade
The Trustees of Columbia University in The City of New York | Undergraduate Degree |
Yale School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Regno Unito | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Founder | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Distribution Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Distribution Services |
Astellas Institute for Regenerative Medicine
Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Health Technology |
- Borsa valori
- Insiders
- Eddy Anglade
- Esperienza